[
  {
    "date": "2023-12-30",
    "symbol": "TFFP",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 5478113,
    "researchanddevelopmenttaxincentivereceivable": 433852,
    "prepaidexpenseandotherassetscurrent": 1678353,
    "assetscurrent": 7590318,
    "operatingleaserightofuseasset": 119529,
    "propertyplantandequipmentnet": 1999781,
    "notesreceivablefairvaluedisclosure": 2310000,
    "otherassetsnoncurrent": 7688,
    "assets": 12027316,
    "accountspayablecurrent": 958442,
    "accruedliabilitiescurrent": 1285586,
    "deferredrevenuecurrent": 101000,
    "operatingleaseliabilitycurrent": 83512,
    "liabilitiescurrent": 2428540,
    "operatingleaseliabilitynoncurrent": 31742,
    "liabilities": 2460282,
    "commonstockvalue": 2370,
    "additionalpaidincapitalcommonstock": 128044509,
    "accumulatedothercomprehensiveincomelossnetoftax": -148192,
    "retainedearningsaccumulateddeficit": -118331653,
    "stockholdersequity": 9567034,
    "liabilitiesandstockholdersequity": 12027316,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 180000000,
    "commonstocksharesissued": 2370000,
    "commonstocksharesoutstanding": 2370000,
    "revenues": 733871,
    "researchanddevelopmentexpense": 12061422,
    "generalandadministrativeexpense": 10567111,
    "operatingexpenses": 22628533,
    "operatingincomeloss": -21894662,
    "investmentincomeinterest": 266188,
    "changeinfairvalueofnotereceivable": 385243,
    "nonoperatingincomeexpense": 651431,
    "netincomeloss": -21243231,
    "othercomprehensiveincomelossforeigncurrencytransactionandtranslationadjustmentnetoftax": -8897,
    "comprehensiveincomenetoftax": -21252128,
    "earningspersharebasic": -11.85,
    "weightedaveragenumberofsharesoutstandingbasic": 1792551,
    "earningspersharediluted": -11.85,
    "weightedaveragenumberofdilutedsharesoutstanding": 1792551,
    "stockissuedduringperiodvalueissuedforservices": 7,
    "salesofcommonstockthroughtheatthemarketofferinginshares": 7062,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 108700,
    "stockissuedduringperiodvaluenewissues": 915,
    "stockissuedduringperiodsharesnewissues": 915216,
    "cashpaidforfractionalsharesresultingfromreversestocksplit": -2875,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 2926291,
    "temporaryequityforeigncurrencytranslationadjustments": -8897,
    "sharebasedcompensation": 2926291,
    "interestaccruedonnotereceivable": 111782,
    "fairvalueadjustmentofnotereceivable": -385243,
    "inventorywritedown": 747348,
    "depreciationdepletionandamortization": 502480,
    "increasedecreaseinresearchanddevelopmenttaxincentivereceivable": 259797,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -1480729,
    "increasedecreaseinaccountspayable": 38382,
    "increasedecreaseinaccruedliabilities": 367093,
    "increasedecreaseindeferredrevenue": -25000,
    "increasedecreaseinoperatingleaseliability": -75465,
    "netcashprovidedbyusedinoperatingactivities": -16038195,
    "paymentstoacquirepropertyplantandequipment": 94750,
    "netcashprovidedbyusedininvestingactivities": -94750,
    "proceedsfromissuanceofcommonstock": 60265,
    "paymentsoffinancingcosts": 108700,
    "proceedsfromissuanceinitialpublicoffering": 5064722,
    "paymentstosettlefractionalsharesresultingfromreversestocksplit": 2875,
    "netcashprovidedbyusedinfinancingactivities": 5013412,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalents": -14669,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -11134202,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 5478113,
    "financingobtainedforinsurancepremiums": 914063,
    "geographicconcentrationspolicytextblock": "GeographicConcentrations",
    "researchanddevelopmentexpensesandrelatedprepaidandaccruedexpensespolicytextblock": "Research and Development Expenses and Related Prepaid and AccruedExpenses",
    "researchanddevelopmenttaxincentivepolicytextblock": "Researchand Development Tax Incentive",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 233340,
    "operatingleasepayments": 115254,
    "operatingleasecost": 89100,
    "shorttermleasecost": 77210,
    "leasecost": 166310,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y4M24D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "operatingleaseleaseincomeleasepayments": 88050,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 91000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 38000,
    "lesseeoperatingleaseliabilitypaymentsdue": 129000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 14000,
    "operatingleaseliability": 115000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisassetvalue": 2310000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisaccruedinterestreceivable": 111782,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 248216,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityrangeofexerciseprice": 7.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingweightedaverageexerciseprice": 42.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P4Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsgranted": 18304,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityrangeofexercisepriceissued": 7.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsissuedweightedaverageexerciseprice": 7.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpirations": 157,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityrangeofexercisepriceexpired": 62.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsexpiredweightedaverageexerciseprice": 62.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecreaseweightedaverageexerciseprice": 22.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 15.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0344,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 233340,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 74.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 138837,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 22.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 21860,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 142.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y7M28D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 107752,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 108.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y29D",
    "deferredfederalincometaxexpensebenefit": -5119585,
    "deferredstateandlocalincometaxexpensebenefit": -29214,
    "deferredforeignincometaxexpensebenefit": -25908,
    "taxadjustmentssettlementsandunusualprovisions": 5174707,
    "deferredtaxassetsoperatinglosscarryforwards": 17989784,
    "deferredtaxassetsinprocessresearchanddevelopment": 3261950,
    "deferredtaxassetsinamortization": 4454248,
    "deferredtaxassetsgoodwillandintangibleassets": 375916,
    "deferredtaxassetsstockcompensation": 1527808,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": -77399,
    "deferredtaxassetsgross": 27532307,
    "deferredtaxassetsvaluationallowance": 27532307,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": -0.0038,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.0064,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.0413,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.2411,
    "uncertaintaxpositionsbegnningbalance": 794851,
    "additionsfortaxpositionsrelatedtocurrentyear": 292466,
    "uncertaintaxpositionsendingbalance": 1087317,
    "entityincorporationdateofincorporation": "2018-01-24",
    "saleofstocknumberofsharesissuedintransaction": 7062,
    "saleofstockpricepershare": 8.8,
    "netproceedsofinitialpublicoffering": 60000,
    "workingcapitalsurplus": 5200000,
    "propertyplantandequipmentsalvagevaluepercentage": 1,
    "cash": 285827,
    "constructioninprogressgross": 0.7,
    "researchanddevelopmenttaxpercentage": 0.435,
    "reductiontoresearchanddevelopmentexpenses": 259797,
    "interestexpense": 14475,
    "paymentsforfees": 500000,
    "debtinstrumentfaceamount": 1812975,
    "debtinstrumentinterestrateeffectivepercentage": 0.06,
    "debtconversionconvertedinstrumentamount1": 15000000,
    "proceedsfromissuanceoffinancing": 15000000,
    "proceedsfromunderwrittenpublicoffering": 35000000,
    "debtinstrumentredemptionpricepercentageofprincipalamountredeemed": 1,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 3800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y10M24D",
    "operatinglosscarryforwards": 84366128,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 4349267,
    "deferredtaxassetstaxcreditcarryforwards": 841000,
    "corporateratepercentage": 0.15,
    "otherincome": 1000000000,
    "excisetaxsurchargepercentage": 0.01,
    "valuationallowanceondeferredtaxassets": 1,
    "uncertaintaxpositions": 1087317,
    "unrecognizedtaxbenefitsincometaxpenaltiesandinterestaccrued": 1087317,
    "sbirgrantoverperiod": "P3Y",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "false",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "TFF Pharmaceuticals, Inc.",
    "entitycentralindexkey": 1733413,
    "entityfilenumber": "001-39102",
    "entitytaxidentificationnumber": "82-4344737",
    "entityincorporationstatecountrycode": "DE",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityaddressaddressline1": "1751 River Run",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "Fort Worth",
    "entityaddressstateorprovince": "TX",
    "entityaddresspostalzipcode": 76107,
    "cityareacode": "(817)",
    "localphonenumber": "438-6168",
    "security12btitle": "Common stock: Par value $0.001",
    "tradingsymbol": "TFFP",
    "securityexchangename": "NASDAQ",
    "auditorname": "Marcum llp",
    "auditorfirmid": 688,
    "auditorlocation": "New York, NY"
  },
  {
    "date": "2022-12-30",
    "symbol": "TFFP",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 16612315,
    "researchanddevelopmenttaxincentivereceivable": 186507,
    "prepaidexpenseandotherassets": 2226344,
    "assetscurrent": 19025166,
    "operatingleaserightofuseasset": 196044,
    "propertyplantandequipmentnet": 3078342,
    "otherassetsnoncurrent": 7688,
    "notereceivable": 1812975,
    "assets": 24120215,
    "accountspayablecurrent": 919607,
    "accruedcompensationliabilities": -4430,
    "otherliabilitiescurrent": 126000,
    "operatingleaseliabilitycurrent": 80625,
    "liabilitiescurrent": 1130662,
    "operatingleaseliabilitynoncurrent": 110094,
    "liabilities": 1240756,
    "commonstockvalue": 36193,
    "additionalpaidincapital": 120070983,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": -139295,
    "retainedearningsaccumulateddeficit": -97088422,
    "stockholdersequity": 22879459,
    "liabilitiesandstockholdersequity": 24120215,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 45000000,
    "commonstocksharesissued": 36193085,
    "commonstocksharesoutstanding": 36193085,
    "revenues": 495805,
    "researchanddevelopmentexpense": 18496340,
    "generalandadministrativeexpense": 13796255,
    "operatingexpenses": 32292595,
    "operatingincomeloss": -31796790,
    "interestincomeexpensenet": 26728,
    "nonoperatingincomeexpense": 26728,
    "profitloss": -31770062,
    "earningspersharebasic": -1.06,
    "weightedaveragenumberofsharesoutstandingbasic": 29979776,
    "netincomelossattributabletononcontrollinginterest": -31770062,
    "foreigncurrencytranslationadjustments": 90374,
    "othercomprehensiveincomelosstax": -31860436,
    "earningspersharediluted": -1.06,
    "weightedaveragenumberofdilutedsharesoutstanding": 29979776,
    "sharesoutstanding": 36193085,
    "stockissuedduringperiodvalueissuedforservices": 104,
    "stockissuedduringperiodsharesnewissues": 104011,
    "stockandwarrantsissuedduringperiodvaluepreferredstockandwarrants": 10675,
    "stockissuedduringperiodsharesconversionofunits": 10675001,
    "issuanceofcommonstockforstockoptionexercises": 42,
    "issuanceofcommonstockforstockoptionexercisesshares": -42292,
    "sharebasedcompensation": 4251833,
    "foreigncurrencytranslationadjustment": -90374,
    "netincomeloss": -31770062,
    "stockbasedcompensation": 4251833,
    "depreciationdepletionandamortization": 388221,
    "receivableduefromcollaborationsagreement": 184272,
    "researchanddevelopmenttaxincentivereceivables": -751403,
    "increasedecreaseinprepaidexpense": -181604,
    "increasedecreaseinaccountspayable": -577105,
    "increasedecreaseinaccruedsalaries": -412480,
    "increasedecreasedeferredresearchgrantrevenue": -76000,
    "increasedecreaseinoperatingleaseliability": -47302,
    "netcashprovidedbyusedinoperatingactivities": -27342160,
    "paymentstoacquirepropertyplantandequipment": 1551326,
    "netcashprovidedbyusedininvestingactivities": -1551326,
    "proceedsfromissuanceofcommonstockvalue": 404555,
    "conversionofseriespreferredstockincludingaccrueddividendstocommonstock": -11235626,
    "proceedsfromissuanceofcommonstockforstockoptionexercises": -110822,
    "netcashprovidedbyusedinfinancingactivities": 11751003,
    "effectofexchangeratechangesoncashandcashequivalent": -39874,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -17182357,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 16612315,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 238021,
    "stockissued1": 1812975,
    "noncashorpartnoncashacquisitionpayablesassumed1": 13400,
    "goingconcernandmanagementsplanstextblock": "NOTE 2 – GOING CONCERN AND MANAGEMENT’SPLANS",
    "licenseandagreementdisclosuretextblock": "NOTE5 – LICENSE AND AGREEMENTS",
    "warrantstextblock": "NOTE7 – WARRANTS",
    "geographicconcentrationspolicytextblock": "GeographicConcentrations",
    "collaborativearrangementspolicytextblock": "CollaborativeArrangements",
    "researchanddevelopmenttaxincentivepolicytextblock": "Researchand Development Tax Incentive",
    "commonstockwarrantspolicytextblock": "CommonStock Warrants",
    "scheduleofunrecognizedtaxpositionstabletextblock": "Federal    and State       Balance    at December 31, 2021     $261,920       Additions    for tax positions related to current year      532,931       Decreases    for tax positions related to prior years      -       Balance    at December 31, 2022     $794,851",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2909057,
    "operatingleaserightofuseassetamortizationexpense": 196044,
    "operatingleaseliabilitycurrentportion": 80625,
    "longtermdebtandcapitalleaseobligationscurrent": 110094,
    "operatingleaseliability": 190719,
    "operatingleasecost": 51975,
    "shorttermleasecost": 20815,
    "leasecost": 156660,
    "operatingleaseweightedaverageremainingleaseterm1": "P2Y4M24D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "operatingleaseleaseincomeleasepayments": 57300,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 112000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 91000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 38000,
    "lesseeoperatingleaseliabilitypaymentsduegross": 241000,
    "receivablewithimputedinterestnetamount": 19000,
    "operatingleasesfutureminimumpaymentsdue": 222000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5751734,
    "sharebasedcompensationarrangementbysharebasedpaymentawardwarrantsrangeofexercisepriceoutstandingsprice": 1.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 1.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardwarrantissuedinperiodgross": 5362501,
    "sharebasedcompensationarrangementbysharebasedpaymentawardwarrantsrangeofexercisepriceissuedprice": 1.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsissuedweightedaverageexerciseprice": 1.31,
    "weightedaverageremaininglifeoutstandingending": "P4Y9M18D",
    "stockbasedcompensationexpenses": 908712,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecreaseweightedaverageexerciseprice": 3.71,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y3M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0241,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingnumber": 2909057,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageexerciseprice": 5.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 24279,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 456393,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.71,
    "stockissuedduringperiodsharesstockoptionesexercised": 42292,
    "weightedaverageexercisepricesoutstandingexercised": 2.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 398883,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 7.53,
    "sharebasedcompensationsarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm3": "P7Y5M15D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1189267,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y8M8D",
    "deferredfederalincometaxexpensebenefit": -7871979,
    "deferredforeignincometaxexpensebenefit": 453410,
    "taxadjustmentssettlementsandunusualprovisions": 7418569,
    "deferredtaxassetsoperatinglosscarryforwards": 15321270,
    "deferredtaxassetsinprocessresearchanddevelopment": 186507,
    "deferredtaxassetsinamortization": 3437763,
    "deferredtaxassetsgoodwillandintangibleassets": 175334,
    "deferredtaxassetsstockcompensation": 1029447,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": -173,
    "deferredtaxassetsgross": 22348195,
    "deferredtaxassetsvaluationallowance": 22348195,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationotherreconcilingitemspercentforeignindollars": -0.0031,
    "effectiveincometaxratereconciliationpermanentbooktaxdifferences": -0.0094,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.0503,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.2478,
    "additionsfortaxpositionsrelatedtocurrentyear": 532931,
    "uncertaintaxpositionsendingbalance": 794851,
    "incomelossfromcontinuingoperations": 31800000,
    "netcashprovidedbyusedinoperatingactivitiescontinuingoperations": 27300000,
    "cashandcashequivalents": 16600000,
    "surplusnotes": 17900000,
    "retainedearningsappropriated": 97100000,
    "netproceeds": 405000,
    "percentageofnetpropertyandequipment": 1,
    "restrictedcash": 1028616,
    "propertyplantandequipmentestimatedusefullives": "two",
    "propertyandequipment": 1493000,
    "leaseterm": "P1Y",
    "valueofresearchanddevelopmentexpense": 495805,
    "prepaidexpenseandotherassetscurrent": 92781,
    "deferredresearchgrantrevenue": 126000,
    "researchanddevelopmenttaxpercentage": 0.435,
    "agreementtremdescription": "In January2019, the Company cancelled all of the individual study contracts with ITR and entered into contracts with 11036114 Canada Inc. (initiallydba VJO Non-Clinical Development and now dba Strategy Point Innovations (“SPI”)) and 11035835 Canada Inc., (dba PeriscopeResearch) to complete additional pre-clinical research and development services in order to take advantage of eligible Canadian Tax Credits.",
    "otherresearchanddevelopmentexpense": 2419000,
    "milestonefee": 25000,
    "accountspayablecurrentandnoncurrent": 176000,
    "interstfee": 500000,
    "otherreceivables": 1812975,
    "saleofstocknumberofsharesissuedintransaction": 42292,
    "proceedsfromstockoptionsexercised": 110822,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 339000,
    "sharebasedgoodsandnonemployeeservicestransactionmodificationoftermsincrementalcompensationcost": 160000,
    "federalincometaxnetoperatingloss": 71906839,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 3179405,
    "foreignincometaxnetoperatingloss": 736112,
    "valuationallowanceondeferredtaxassets": 1,
    "uncertaintaxpositions": 794851,
    "investmentownedbalanceprincipalamount": 1812975,
    "interestrate": 0.06,
    "subsequenteventsdate": "2026-01-01",
    "dividingamount": 15000000,
    "outstandingprincipalamount": 15000000,
    "grossproceeds": 15000000,
    "outstandingprincipalamountpercentage": 1,
    "entityregistrantname": "TFF Pharmaceuticals, Inc.",
    "tradingsymbol": "TFFP",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "--12-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1733413,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-39102",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "82-4344737",
    "entityaddressaddressline1": "1751 River Run",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "Fort Worth",
    "entityaddressstateorprovince": "TX",
    "entityaddresspostalzipcode": 76107,
    "cityareacode": "(817)",
    "localphonenumber": "438-6168",
    "security12btitle": "Common stock: Par value $0.001",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 688,
    "auditorname": "Marcum llp",
    "auditorlocation": "New York, NY"
  },
  {
    "date": "2021-12-30",
    "symbol": "TFFP",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 33794672,
    "receivableduefromcollaborationagreement": 1628703,
    "researchanddevelopmenttaxincentivereceivable": 966646,
    "prepaidexpenseandotherassets": 2447930,
    "assetscurrent": 38837951,
    "propertyplantandequipmentnet": 1859860,
    "assets": 40697811,
    "accountspayablecurrent": 1493842,
    "accruedcompensationliabilities": -416910,
    "otherliabilitiescurrent": 50000,
    "liabilities": 1960752,
    "commonstockvalue": 25372,
    "additionalpaidincapital": 104078968,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": -48921,
    "retainedearningsaccumulateddeficit": -65318360,
    "stockholdersequity": 38737059,
    "liabilitiesandstockholdersequity": 40697811,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 45000000,
    "commonstocksharesissued": 25371781,
    "commonstocksharesoutstanding": 25371781,
    "revenues": 88161,
    "researchanddevelopmentexpense": 21300865,
    "generalandadministrativeexpense": 10573954,
    "operatingexpenses": 31874819,
    "operatingincomeloss": -31786658,
    "otherincome": 696714,
    "interestincomeexpensenet": 51232,
    "nonoperatingincomeexpense": 747946,
    "profitloss": -31038712,
    "earningspersharebasicanddiluted": -1.25,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 24820971,
    "netincomelossattributabletononcontrollinginterest": -31038712,
    "foreigncurrencytranslationadjustments": -2617,
    "othercomprehensiveincomelosstax": -31036095,
    "sharesoutstanding": 25371781,
    "stockissuedduringperiodvalueother": 2140,
    "stockissuedduringperiodsharesother": 2140000,
    "issuanceofcommonstockforstockoptionexercises": 252,
    "issuanceofcommonstockforstockoptionexercisesshares": -252156,
    "issuanceofcommonstockinconnectionwithcashlesswarrantexercises": 445,
    "issuanceofcommonstockinconnectionwithcashlesswarrantexercisesshares": 444751,
    "sharebasedcompensation": 3548368,
    "foreigncurrencytranslationadjustment": 2617,
    "netincomeloss": -31038712,
    "stockbasedcompensation": 3548368,
    "depreciationdepletionandamortization": 111453,
    "receivableduefromcollaborationsagreement": 1628703,
    "researchanddevelopmenttaxincentivereceivables": 997802,
    "increasedecreaseinprepaidexpense": 203363,
    "increasedecreaseinaccountspayable": 209193,
    "increasedecreaseinaccruedsalaries": 416910,
    "increasedecreasedeferredresearchgrantrevenue": -25685,
    "netcashprovidedbyusedinoperatingactivities": -29556971,
    "paymentstoacquirepropertyplantandequipment": 868505,
    "netcashprovidedbyusedininvestingactivities": -868505,
    "proceedsfromissuanceofcommonstockvalue": 28015019,
    "proceedsfromissuanceofcommonstockforstockoptionexercises": -689752,
    "proceedsfromissuanceofcommonstock": 180213,
    "netcashprovidedbyusedinfinancingactivities": 28884984,
    "effectofexchangeratechangesoncashandcashequivalent": 34359,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -1506133,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 33794672,
    "cashlessexerciseofwarrants": 416,
    "liquidityandmanagementsplanstextblock": "NOTE2 – LIQUIDITY AND MANAGEMENT’S PLANS",
    "licenseandagreementdisclosuretextblock": "NOTE5 – LICENSE AND AGREEMENTS",
    "warrantstextblock": "NOTE7 – WARRANTS",
    "geographicconcentrationspolicytextblock": "GeographicConcentrations",
    "collaborativearrangementspolicytextblock": "CollaborativeArrangements",
    "researchanddevelopmenttaxincentivepolicytextblock": "Researchand Development Tax Incentive",
    "commonstockwarrantspolicytextblock": "CommonStock Warrants",
    "scheduleofunrecognizedtaxpositionstabletextblock": "Federal    and State       Balance    at December 31, 2020     $394,358       Additions    for tax positions related to current year      110,827       Decreases    for tax positions related to prior years      (243,265)      Balance    at December 31, 2021     $261,920",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2893839,
    "operatingleasesfutureminimumpaymentsdue": 30000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 389233,
    "sharebasedcompensationarrangementbysharebasedpaymentawardwarrantsrangeofexercisepriceoutstandingsprice": 2.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.79,
    "sharebasedcompensationarrangementbysharebasedpaymentawardwarrantcancelledinperiodgrossexercised": -453122,
    "rangeofexercisepricesexercisedinshares": 0.01,
    "sharebasedcompensationarrangementbysharebasedweightedaverageexercisepricepricesexercised": 0.74,
    "weightedaverageremaininglifeoutstandingending": "P4Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardwarrantissuedinperiodgross": 25000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardwarrantsrangeofexercisepriceissuedprice": 15.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsissuedweightedaverageexerciseprice": 15.9,
    "stockbasedcompensationexpenses": 459492,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecreaseweightedaverageexerciseprice": 8.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0081,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingnumber": 2893839,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageexerciseprice": 6.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 9932413,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 535500,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8.86,
    "stockissuedduringperiodsharesstockoptionesexercised": 252156,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.74,
    "sharebasedcompensationsarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm3": "P8Y18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1219841,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y5M15D",
    "aggregateintrinsicvalueexercisables": 5730660,
    "deferredfederalincometaxexpensebenefit": -6076003,
    "deferredforeignincometaxexpensebenefit": -240902,
    "taxadjustmentssettlementsandunusualprovisions": 6316905,
    "deferredtaxassetsoperatinglosscarryforwards": 13087758,
    "deferredtaxassetsinprocessresearchanddevelopment": 966646,
    "deferredtaxassetsgoodwillandintangibleassets": 143854,
    "deferredtaxassetsstockcompensation": 1054242,
    "deferredtaxassetsgross": 15071615,
    "deferredtaxassetsvaluationallowance": 15071615,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationotherreconcilingitemspercentforeignindollars": -0.0054,
    "effectiveincometaxratereconciliationpermanentbooktaxdifferences": -0.0195,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.0107,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.1958,
    "additionsfortaxpositionsrelatedtocurrentyear": 110827,
    "decreasesfortaxpositionsrelatedtoprioryears": 243265,
    "uncertaintaxpositionsendingbalance": 261920,
    "cashandcashequivalents": 33795000,
    "surplusnotes": 36877000,
    "percentageofnetpropertyandequipment": 1,
    "duefromrelatedparties": 831984,
    "propertyplantandequipmentestimatedusefullives": "two",
    "propertyandequipment": 431000,
    "valueofresearchanddevelopmentexpense": 88161,
    "prepaidexpenseandotherassetscurrent": 11996,
    "deferredresearchgrantrevenue": 50000,
    "researchanddevelopmenttaxpercentage": 0.435,
    "otherresearchanddevelopmentexpense": 43837,
    "warrantpurchasecommonshares": 400000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.01,
    "operatingleasecost": 78000,
    "accountspayablecurrentandnoncurrent": 21000,
    "researchanddevelopmentexpenses": 4789000,
    "interstfee": 500000,
    "recordedreceivable": 1628703,
    "issuanceofcommonstockforstockoptionexerciseshares": 252156,
    "stockoptionexercisestotalproceeds": 689752,
    "stockissuedduringperiodsharescashlessexercise": 415917,
    "stockandwarrantsissuedduringperiodvaluewarrants": 424288,
    "exerciseofcommonstockwarrants": 28834,
    "warrantsproceeds": 180213,
    "fairvalueassumptionscommonstockvalue": 16.13,
    "fairvalueassumptionsexpectedterms": "P5Y",
    "fairvalueassumptionexpectedvolatilityrate": 0.9709,
    "fairvalueassumptionriskfreeinterestrate": 0.0042,
    "generalandadministrativeexpenses": 293000,
    "warrantoutstandingaggregateintrinsicvalue": 1432000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 9474000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalueterm": "P2Y6M",
    "federalincometaxnetoperatingloss": 59111972,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1047681,
    "foreignincometaxnetoperatingloss": 2247481,
    "valuationallowanceondeferredtaxassets": 1,
    "uncertaintaxpositions": 261920,
    "entityregistrantname": "TFF Pharmaceuticals, Inc.",
    "tradingsymbol": "TFFP",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "--12-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1733413,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-39102",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "82-4344737",
    "entityaddressaddressline1": "1751 River Run",
    "entityaddressaddressline2": "Suite 400",
    "entityaddresscityortown": "Fort Worth",
    "entityaddressstateorprovince": "TX",
    "entityaddresspostalzipcode": 76107,
    "cityareacode": "(817)",
    "localphonenumber": "438-6168",
    "security12btitle": "Common stock: Par value $0.001",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 688,
    "auditorname": "Marcum LLP",
    "auditorlocation": "New York, NY"
  },
  {
    "date": "2020-12-30",
    "symbol": "TFFP",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 35300805,
    "prepaidexpenseandotherassets": 2258229,
    "assetscurrent": 37559034,
    "propertyplantandequipmentnet": 1102808,
    "assets": 38661842,
    "accountspayablecurrent": 1297725,
    "otherliabilitiescurrent": 24315,
    "liabilitiescurrent": 1322040,
    "liabilities": 1322040,
    "commonstockvalue": 22535,
    "additionalpaidincapital": 71648453,
    "accumulatedothercomprehensiveincomelossforeigncurrencytranslationadjustmentnetoftax": -51538,
    "retainedearningsaccumulateddeficit": -34279648,
    "stockholdersequity": -34279648,
    "liabilitiesandstockholdersequity": 38661842,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 45000000,
    "commonstocksharesissued": 22534874,
    "commonstocksharesoutstanding": 22534874,
    "researchanddevelopmentexpense": 10681565,
    "generalandadministrativeexpense": 8012085,
    "operatingexpenses": 18693650,
    "operatingincomeloss": -18693650,
    "interestincomeexpensenet": 126416,
    "nonoperatingincomeexpense": 126416,
    "profitloss": -18567234,
    "netincomelossavailabletocommonstockholdersbasic": -18567234,
    "earningspersharebasicanddiluted": -0.91,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 20425162,
    "netincomeloss": -18567234,
    "foreigncurrencytranslationadjustments": 51538,
    "othercomprehensiveincomelosstax": -18618772,
    "sharesoutstanding": 22534874,
    "stockissuedduringperiodvalueother": 24280283,
    "stockissuedduringperiodsharesother": 3048654,
    "proceedsfromissuanceofwarrants": 1132013,
    "issuanceofcommonstockforaccruedresearchanddevelopmentexpense": 220666,
    "issuanceofcommonstockforstockoptionexercises": 714382,
    "issuanceofcommonstockforstockoptionexercisesshares": 285003,
    "issuanceofcommonstockinconnectionwithcashlesswarrantexercises": -530,
    "issuanceofcommonstockinconnectionwithcashlesswarrantexercisesshares": 529559,
    "sharebasedcompensation": 2046871,
    "foreigncurrencytranslationadjustment": -51538,
    "stockbasedcompensation": 2187149,
    "increasedecreaseinprepaidexpense": 1122495,
    "increasedecreaseinaccountspayable": 862676,
    "increasedecreasedeferredresearchgrantrevenue": -24315,
    "netcashprovidedbyusedinoperatingactivities": -16615589,
    "paymentstoacquirepropertyplantandequipment": 1102808,
    "netcashprovidedbyusedininvestingactivities": -1102808,
    "proceedsfromissuanceofcommonstockvalue": 24280283,
    "proceedsfromissuanceofcommonstockforstockoptionexercises": -714382,
    "netcashprovidedbyusedinfinancingactivities": 24994665,
    "effectofexchangeratechangesoncashandcashequivalent": -70399,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 7205869,
    "cashlessexerciseofwarrants": 530,
    "conversionofseriespreferredstockincludingaccrueddividendstocommonstock": 1132013,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3027850,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 30000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 817355,
    "sharebasedcompensationarrangementbysharebasedpaymentawardwarrantsrangeofexercisepriceoutstandingprice": 6.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.68,
    "sharebasedcompensationarrangementbysharebasedpaymentawardwarrantcancelledinperiodgrossexercised": -659108,
    "sharebasedcompensationarrangementbysharebasedpaymentawardwarrantspriceexercisepricesexercised": 6.25,
    "sharebasedcompensationarrangementbysharebasedweightedaverageexercisepricepricesexercised": 2.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm": "P3Y255D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingperiodincreasedecreaseweightedaverageexerciseprice": 10.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 9.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0147,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingnumber": 2610495,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionoutstandingweightedaverageexerciseprice": 5.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 22789233,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 782045,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.42,
    "stockissuedduringperiodsharesstockoptionsexercised": 285003,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.74,
    "stockissuedduringperiodsharessharebasedcompensation": -25625,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm3": "P8Y219D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 755885,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 3.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y14D",
    "aggregateintrinsicvalueexercisable": 8365946,
    "deferredfederalincometaxexpensebenefit": -4502016,
    "deferredforeignincometaxexpensebenefit": -480666,
    "taxadjustmentssettlementsandunusualprovisions": 4982682,
    "operatinglosscarryforwards": 6807300,
    "deferredtaxassetsinprocessresearchanddevelopment": 1092345,
    "deferredtaxassetsgoodwillandintangibleassets": 136226,
    "deferredtaxassetsstockcompensation": 761741,
    "deferredtaxassetsgross": 8797612,
    "deferredtaxassetsvaluationallowance": 8797612,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationotherreconcilingitemspercentforeignindollars": -0.0181,
    "effectiveincometaxratereconciliationpermanentbooktaxdifferences": -0.0026,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.0509,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.2402,
    "additionsfortaxpositionsrelatedtocurrentyear": 318374,
    "decreasesfortaxpositionsrelatedtoprioryears": -81830,
    "uncertaintaxpositionsendingbalance": 394358,
    "preconfirmationcashandcashequivalents": 35301000,
    "surplusnotes": 36237000,
    "maintenanceofpropertyandequipment": 1,
    "cash": 214240,
    "propertyplantandequipmentusefullife": "P5Y",
    "deferredresearchgrantrevenue": 24315,
    "weightedaveragenumberofsharesoutstandingbasic": 400000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.01,
    "debtinstrumentconvertibleconversionprice1": 2.5,
    "conversionpricepercentage": 0.5,
    "saleofstockpricepershare": 5,
    "debtinstrumentconvertiblebeneficialconversionfeature": 23930000,
    "expiredate": "The lease commenced on October 15, 2018, the Company exercised a one-year lease renewal in October 2019, and another one-year lease renewal in October 2020 that will expire on October 31, 2021.",
    "leaseandrentalexpense": 36000,
    "operatingleasecost": 59000,
    "milestonefee": 50000,
    "commonshareoutstandingpricepercentage": 0.01,
    "otherresearchanddevelopmentexpense": 557000,
    "researchanddevelopmentinprocess": 1824000,
    "premarketingapprovals": 25000000,
    "issuanceofcommonstockforstockoptionexerciseshares": 285003,
    "stockoptionexercisestotalproceeds": 714382,
    "issuanceofcommonstockinconnectionwithcashlesswarrantexercise": 529559,
    "issuanceofcommonstockwarrant": 659108,
    "warrantoutstandingaggregateintrinsicvalue": 9511000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 9074000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalueterm": "P2Y146D",
    "federalincometaxnetoperatingloss": 30126830,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1486704,
    "foreignincometaxnetoperatingloss": 1602220,
    "federaltaxcreditexpire": 2040,
    "taxableincomeforlosses": 0.8,
    "uncertaintaxpositions": 394358,
    "entityregistrantname": "TFF Pharmaceuticals, Inc.",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "--12-31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1733413,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "entityfilenumber": "001-39102",
    "entityincorporationstatecountrycode": "DE",
    "entityinteractivedatacurrent": "Yes"
  }
]